Reversible cerebral vasoconstriction syndrome resulted in cerebral infarction after allogeneic stem cell transplantation: a case report.
Division of Endocrinology and Metabolism, Hematology, Rheumatology and Respiratory Medicine, Department of Internal Medicine, Faculty of Medicine, Kagawa University, Kagawa, Japan, oima@med.kagawa-u.ac.jp.
Osamu
O
Imataki
Makiko
M
Uemura
Takamichi
T
Shintani
Kensuke
K
Matsumoto
D002536:Cerebral Arteries / Q000187:drug effects* / Q000473:pathology; D002544:Cerebral Infarction / Q000139:chemically induced / Q000473:pathology* / Q000503:physiopathology; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D008875:Middle Aged; D054038:Posterior Leukoencephalopathy Syndrome / Q000139:chemically induced / Q000473:pathology* / Q000503:physiopathology; D033581:Stem Cell Transplantation; D016559:Tacrolimus / Q000009:adverse effects*; D014184:Transplantation, Homologous; D014661:Vasoconstriction
D007166:Immunosuppressive Agents; D016559:Tacrolimus